scholarly article | Q13442814 |
P356 | DOI | 10.1093/INFDIS/159.1.151 |
P698 | PubMed publication ID | 2909637 |
P2093 | author name string | S Manzi | |
J O Moore | |||
J Perfect | |||
A J Herzberg | |||
A Sane | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | deferoxamine | Q419618 |
P304 | page(s) | 151-152 | |
P577 | publication date | 1989-01-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Deferoxamine treatment as a risk factor for zygomycete infection | |
P478 | volume | 159 |
Q28067212 | A Review on Iron Chelators in Treatment of Iron Overload Syndromes |
Q44357651 | Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). |
Q33998041 | Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species |
Q43825222 | Indolent zygomycosis associated with deferoxamine chelation therapy |
Q38704400 | Mucormycosis: association with deferoxamine therapy |
Q42873307 | Restoration of Hematopoiesis After Iron Chelation Therapy With Deferasirox in 2 Children With Severe Aplastic Anemia |
Q37849630 | The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate |
Search more.